Skip to main content
. 2009 Dec;4(12):1932–1938. doi: 10.2215/CJN.02940509

Table 1.

Demographics, dialysis treatment, and biochemical variables

Variable
Age (yr) (median, minimum − maximum) 75 (30–87)
Sex (man/woman) [n (%)] 40/35 (54/46)
Vintage (mo) 20 (9–31.5)
Qb,effective (ml/min) 304.0 (40.1)
Qd (ml/min) 505.6 (22.7)
Unipuncture/bipuncture [n (%)] 8/67 (11–89)
Residual renal function (yes versus no) (%) 39/36 (52/48)
Urea (mg/dl) 119.3 (26.9)
Creatinine (mg/dl) 6.9 (2.1)
Albumin (mg/L) 39.5 (3.5)
Total p-cresyl sulfate (μM) 183.6 (114.4–305.3)
Free p-cresyl sulfate (μM) 10.3 (5.6–19.9)
Free fraction p-cresyl sulfate 0.054 (0.042–0.070)
Total indoxyl sulfate (μM) 104.7 (67.2–134.6)
Free indoxyl sulfate (μM) 9.1 (5.4–12.5)
Free fraction indoxyl sulfate 0.081 (0.068–0.106)

Data are expressed as mean (SD) or median (25–75 percentile) as appropriate. To convert creatinine in mg/dl to μM, multiply with 88.4.

Qb,effective, effective blood flow; Qd, dialysate flow.

HHS Vulnerability Disclosure